Transcatheter aortic valve replacement in low-risk patients: an updated meta-analysis of randomized controlled trials
TAVR in low-risk patients with AS results in reduced 1-year all-cause mortality and rehospitalization rates as compared with SAVR. This benefit is attenuated during protracted follow-up.
Authors
- Jesslyn Hariyanto
- Roel Meeus (ORCID: https://orcid.org/0009-0003-5454-2032)
- Leen Van Langenhoven (ORCID: https://orcid.org/0009-0005-0499-7148)
- Lennert Minten (ORCID: https://orcid.org/0000-0001-5290-6320)
- Christophe Dubois (ORCID: https://orcid.org/0000-0001-5255-1443)
- Hadiah Ashraf
- Pavell Dhondt
- Caroline O Fischer-Bacca
- Caterina Lecchi
Institutions
- University of Trieste (IT)
- Rawalpindi Medical University (PK)
- Statistics Belgium (BE)
- Universitas Muhammadiyah Tangerang (ID)
- Universidade para o Desenvolvimento do Alto Vale do Itajaí (BR)
- KU Leuven (BE)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-05-03
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101692
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78